O'Sullivan, C., Edgerly, M., Velarde, M., Wilkerson, J., Venkatesan, A. M., Pittaluga, S., . . . Fojo, T. (2014). The VEGF Inhibitor Axitinib Has Limited Effectiveness as a Therapy for Adrenocortical Cancer. Endocrine Society.
Παραπομπή Chicago StyleO'Sullivan, Ciara, et al. The VEGF Inhibitor Axitinib Has Limited Effectiveness As a Therapy for Adrenocortical Cancer. Endocrine Society, 2014.
Παραπομπή MLAO'Sullivan, Ciara, et al. The VEGF Inhibitor Axitinib Has Limited Effectiveness As a Therapy for Adrenocortical Cancer. Endocrine Society, 2014.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.